Find Reports
Select Report Type
Reimbursement Review
Displaying 951 - 975 of 1426
Please scroll or swipe to the right to view the full content.
| Title | Brand Name | Generic Name | Files | Therapeutic Area | Recommendation Type | Status | Submission Date | Recommendation Date Sort ascending | Project Number |
|---|---|---|---|---|---|---|---|---|---|
| Darunavir | Prezista | Darunavir | HIV (treatment naive) | List with clinical criteria and/or conditions | Complete | SR0163-000 | |||
| Desvenlafaxine succinate | Pristiq | Desvenlafaxine succinate | Depressive, Major Disorder (MDD) | Do not list | Complete | SR0159-000 | |||
| Pregabalin | Lyrica | Pregabalin | diabetic peripheral neuropathy | Do not list | Complete | SR0162-000 | |||
| Insulin detemir | Levemir | Insulin detemir | Diabetes mellitus | Do not list | Complete | SR0160-000 | |||
| Insulin detemir | Levemir | Insulin detemir | Diabetes mellitus Type1, Pediatrics | Do not list | Complete | SR0172-000 | |||
| Levodopa / carbidopa | Duodopa | Levodopa / carbidopa | Parkinson's disease | Do not list | Complete | SR0154-000 | |||
| Teriparatide (rDNA origin) inj... | Forteo | Teriparatide (rDNA origin) injection | Osteoporosis, glucocorticoid induced | Do not list | Complete | SR0152-000 | |||
| Alendronate sodium / cholecalc... | Fosavance 70/5600 | Alendronate sodium / cholecalciferol | Osteoporosis | List in a similar manner to other drugs in class | Complete | SR0153-000 | |||
| Ustekinumab | Stelara | Ustekinumab | Psoriasis | List with clinical criteria and/or conditions | Complete | SR0156-000 | |||
| Solifenacin succinate | Vesicare | Solifenacin succinate | Bladder, overactive | List with clinical criteria and/or conditions | Complete | SR0155-000 | |||
| Olmesartan medoxomil + hydroch... | Olmetec Plus | Olmesartan medoxomil + hydrochlorothiazide | Hypertension | List in a similar manner to other drugs in class | Complete | SR0151-000 | |||
| Olmesartan medoxomil | Olmetec | Olmesartan medoxomil | Hypertension | List in a similar manner to other drugs in class | Complete | SR0150-000 | |||
| Abatacept | Orencia | Abatacept | Arthritis, Juvenile Idiopathic & Juvenile Rheumatoid | List with clinical criteria and/or conditions | Complete | SR0145-000 | |||
| Infliximab | Remicade | Infliximab | Ulcerative Colitis | Do not list | Complete | SR0146-000 | |||
| Darifenacin hydrobromide | Enablex | Darifenacin hydrobromide | Bladder, overactive | List with clinical criteria and/or conditions | Complete | SR0147-000 | |||
| Tenofovir disoproxil fumarate | Viread | Tenofovir disoproxil fumarate | Hepatitis B (chronic) | List with clinical criteria and/or conditions | Complete | SR0148-000 | |||
| Natalizumab | Tysabri | Natalizumab | Multiple Sclerosis, relapsing-remitting | List with clinical criteria and/or conditions | Complete | SR0133-000 | |||
| Insulin glulisine | Apidra | Insulin glulisine | Diabetes, Mellitus (Type 1 & 2) | List in a similar manner to other drugs in class | Complete | SR0144-000 | |||
| Dabigatran etexilate | Pradaxa | Dabigatran etexilate | Thromboembolism (venous), prevention | Do not list | Complete | SR0140-000 | |||
| Sodium oxybate | Xyrem | Sodium oxybate | Narcolepsy | Do not list | Complete | SR0141-000 | |||
| Sitaxsentan sodium | Thelin | Sitaxsentan sodium | Pulmonary arterial hypertension (WHO class II and III) | Do not list | Complete | SR0132-000 | |||
| Methylnaltrexone bromide | Relistor | Methylnaltrexone bromide | Constipation, Opioid-induced | Do not list | Complete | SR0135-000 | |||
| Ambrisentan | Volibris | Ambrisentan | Pulmonary arterial hypertension (WHO class II and III) | List with clinical criteria and/or conditions | Complete | SR0142-000 | |||
| Emtricitabine/tenofovir disopr... | Truvada | Emtricitabine/tenofovir disoproxil fumarate | HIV infection | List with clinical criteria and/or conditions | Complete | SF0138-000 | |||
| Rivaroxaban | Xarelto | Rivaroxaban | Thromboembolism (venous), prevention | List with clinical criteria and/or conditions | Complete | SR0134-000 |
Health Technology Review
Displaying 601 - 602 of 602
Horizon Scan
Displaying 101 - 110 of 110
Projects in Progress
Displaying 26 - 27 of 27
View All Reports
Displaying 951 - 975 of 2138
Please scroll or swipe to the right to view the full content.
| Title | Description | Files | Last Updated Sort ascending | Project Line | Project Sub Line | Status | Project Number |
|---|---|---|---|---|---|---|---|
| Digital Pathology Using Primary Case Sign-Out | Health Technology Review | Rapid Review | Completed | RC1395-000 | |||
| Adaptive Deep Brain Stimulation for the Treatment of Parkinson Disease and Essential Tremor | Horizon Scan | Health Technology Update | Completed | EN0036-000 | |||
| Cardiac Monitoring for Adolescents With Eating Disorders | Health Technology Review | Rapid Review | Completed | RC1396-000 | |||
| International Plasma Collection Practices | Health Technology Review | Environmental Scan | Completed | ES0356-000 | |||
| Homelike Models of Long-Term Care: A 2021 Update | Health Technology Review | Rapid Review | Completed | RC1393-000 | |||
| CADTH Pharmaceutical Reviews Update — Issue 26 | Reimbursement Review | Pharmaceutical Review Update | |||||
| Nabilone for the Treatment of Post-Traumatic Stress Disorder: A 2021 Update | Health Technology Review | Rapid Review | Completed | RC1394-000 | |||
| Lenalidomide Plus Rituximab Chemotherapy for Relapsed or Refractory Indolent B-Cell Non-Hodgkin Lymphomas | Health Technology Review | Rapid Review | RC1392-000 | ||||
| Cognitive Remediation Therapy for People With Schizophrenia Spectrum Disorder: A Rapid Qualitative Review | Health Technology Review | Rapid Review | Completed | RC1387-000 | |||
| givosiran | Reimbursement Review | Complete | SR0679-000 | ||||
| incobotulinumtoxinA | Reimbursement Review | Complete | SR0678-000 | ||||
| Computed Tomography Derived Fractional Flow Reserve for the Diagnosis of Coronary Artery Disease | Health Technology Review | Rapid Review | Completed | RC1389-000 | |||
| larotrectinib | Reimbursement Review | Complete | PC0221-000 | ||||
| Colorectal Cancer | Reimbursement Review | Provisional Funding Algorithm | Complete | PH0005-000 | |||
| Biologics in Plaque Psoriasis | Health Technology Review | Environmental Scan | Completed | ES0357-000 | |||
| Medication Administration with Inhalers or Nebulizers | Health Technology Review | Rapid Review | RC1390-000 | ||||
| dapagliflozin | Reimbursement Review | Complete | SR0642-000 | ||||
| risperidone | Reimbursement Review | Complete | SR0671-000 | ||||
| Pharmacological Thromboprophylaxis in Patients With Cancer | Health Technology Review | Rapid Review | Completed | RC1391-000 | |||
| budesonide/ glycopyrronium /formoterol fumarate | Reimbursement Review | Complete | SR0675-000 | ||||
| elexacaftor / tezacaftor / ivacaftor and ivacaftor | Reimbursement Review | Complete | SR0673-000 | ||||
| risdiplam | Reimbursement Review | Complete | SR0661-000 | ||||
| brexucabtagene autoleucel | Reimbursement Review | Complete | PG0219-000 | ||||
| daunorubicin and cytarabine | Reimbursement Review | Complete | PC0237-000 | ||||
| Single-Use Negative Pressure Wound Therapy for Chronic Wounds | Health Technology Review | Rapid Review | RC1385-000 |
Provisional Funding Algorithm
Displaying 76 - 81 of 81